We have isolated a variant line of mouse L cells, termed gro2C, which is partially resistant to infection by herpes simplex virus type 1 (HSV-1). Characterization of the genetic defect in gro2C cells revealed that this cell line harbors a specific defect in the heparan sulfate synthesis pathway. Specifically, anion-exchange highperformance liquid chromatography of metabolically radiolabeled glycosaminoglycans indicated that chondroitin sulfate moieties were synthesized normally in the mutant cells, whereas heparin-like chains were absent. Because of these properties, we have used these cells to investigate the role of heparan sulfate proteoglycans in the HSV-1 life cycle. In this report, we demonstrate that the partial block to HSV-1 infection in gro2C cells occurs in the virus entry pathway. Virus adsorption assays using radiolabeled HSV-1 (KOS) revealed that the gro2C cell surface is a relatively poor target for HSV-1 in that virus attachment was 85% lower in the mutant cells than in the parental L cell controls. A portion of the 15% residual virus adsorption was functional, however, insofar as gro2C cells were susceptible to HSV-1 infection in plaque assays and in single-step growth experiments. Moreover, although the number of HSV-1 plaques that formed in gro2C monolayers was reduced by 85%, the plaque morphology was normal, and the virus released from the mutant cells was infectious. Taken together, these results provide strong genetic evidence that heparan sulfate proteoglycans enhance the efficiency of HSV attachment to the cell surface but are otherwise not essential at any stage of the lytic cycle in culture. Moreover, in the absence of heparan sulfate, other cell surface molecules appear to confer susceptibility to HSV, leading to a productive viral infection.
gro2C cell surface is a relatively poor target for HSV-1 in that virus attachment was 85% lower in the mutant cells than in the parental L cell controls. A portion of the 15% residual virus adsorption was functional, however, insofar as gro2C cells were susceptible to HSV-1 infection in plaque assays and in single-step growth experiments. Moreover, although the number of HSV-1 plaques that formed in gro2C monolayers was reduced by 85%, the plaque morphology was normal, and the virus released from the mutant cells was infectious. Taken together, these results provide strong genetic evidence that heparan sulfate proteoglycans enhance the efficiency of HSV attachment to the cell surface but are otherwise not essential at any stage of the lytic cycle in culture. Moreover, in the absence of heparan sulfate, other cell surface molecules appear to confer susceptibility to HSV, leading to a productive viral infection.
The genome of herpes simplex virus type 1 (HSV-1) encodes an elaborate array of at least 10 glycoproteins, 7 of which have been shown to decorate the virus envelope (reviewed in reference 21) . As for all enveloped viruses, one or more of these proteins appear to facilitate the recognition and penetration of appropriate host cells. Some of the steps in the virus entry pathway have been dissected by the generation of HSV recombinants containing altered forms of one or more glycoproteins. These studies indicate that viral glycoproteins gB, gC, gD, and gH all contain determinants that influence virus adsorption or penetration (3, 6, 15) . Although substantial progress is being made in identifying the viral determinants that influence virus entry, less is known about how these determinants recognize and interact with components of the host cell surface.
One area of significant progress in this regard has been the identification by Spear and coworkers of a role for heparan sulfate in the initial interaction of HSV-1 with the host cell (7, 20, 22, 26) . Heparan sulfate is produced by virtually all animal cells and as such is a good candidate for the initial interaction of HSV with the cell surface. Evidence for the involvement of heparan sulfate in the initial events of herpesvirus infection has come from studies showing that soluble heparan sulfate, but not chondroitin sulfate, interferes with HSV infection in some cell types (17) and that enzymatic removal of heparan sulfate from the surface of host cells reduces infection (7, 26) . Furthermore, radiolabeled herpesvirus attaches poorly to CHO cell mutants defective in glycosaminoglycan synthesis (20) . In this study, the CHO mutant cell line pgsD-677, which is defective in heparan sulfate synthesis (14) , was uninfected by HSV-1 * Corresponding author.
(KOS) at multiplicities of infection (MOIs) as high as 150, suggesting a key role for heparan sulfate synthesis in the infection of CHO cells by HSV-1. Type-specific differences were also apparent in that HSV-2 (333) infected pgsD-677 cells relatively efficiently (10% of control). Mutant cells expressing undersulfated proteoglycans were also poor targets for virus infection, suggesting that the extent of sulfation may be a determinant in establishing the affinity of HSV-1 for the cell surface.
The role of proteoglycans in the herpesvirus life cycle has not been fully resolved by these studies, however, because CHO (50 , uCi/ml) . After 2 days to allow virus egress, the extracellular medium was removed from infected-cell monolayers and subjected to low-speed centrifugation to pellet cell debris. The supernatant was sedimented at 10,000 x g for 2 h to pellet virions. This material was suspended in buffer and centrifuged through sucrose gradients formed in 50 mM NaCl-10 mM Tris (pH 7.8). Radiolabeled virus was removed from the gradient and diluted into PBS just prior to use. For determination of radioactivity in insoluble material, 10% of each fraction to be analyzed was added to 50 p,g of bovine serum albumin followed by 1 ml of 10% cold trichloroacetic acid. Insoluble material was collected onto filters after 1 h, and radioactivity was measured by scintillation counting. For determination of titers, virus preparations were diluted serially with growth medium and used to inoculate monolayers of Vero cells growing in six-well dishes. Plaques were scored after 3 and 5 days.
Virus adsorption assays. The assays were modified from those described previously (26) . Approximately (25) .
For high-pressure liquid chromatography (HPLC) analysis, the glycosaminoglycan samples were desalted by precipitation with ethanol (1) . Following centrifugation, the ethanol precipitates were suspended in 20 mM Tris (pH 7.4) and resolved by anion-exchange HPLC, using a TSK DEAE-3SW column (15 by 75 mm; Beckman Instruments). Proteoglycans were eluted from the column by using a linear 50 to 700 mM NaCl gradient formed in 10 mM KH2PO4 (pH 6.0). All buffers contained 0.2% Zwittergent 3-12 (Calbiochem) to extend the life of the column, as reported previously (1) . The glycosaminoglycans in the peaks were identified by digestion of the sample with the relevant enzymes prior to chromatography.
Plaque assays. Mutant or control cells were inoculated with virus in DMEM-2% FCS for 1 h. After 6 to 48 h of incubation, samples of the cells and extracellular medium were harvested and the virus titers were determined. To do this, virus samples were diluted serially in DMEM-10% FCS and used to inoculate confluent monolayers of Vero cells growing in six-well dishes. After inoculation, the monolayers were rinsed and overlaid with either methylcellulose or growth medium supplemented with 0.1% pooled human immunoglobulin G. Plaques were scored after 3 and 5 days.
Comparison Characterization of glycosaminoglycan synthesis in gro2C cells. It has been shown that HSV-1 (KOS) is unable to efficiently attach to or infect the CHO cell mutant pgsD-677 (20) , which has a specific defect in heparan sulfate biosynthesis (13) . From the results of the virus attachment assays (Fig. 1 synthesis. We conclude from these results that gro2C cells are unable to generate the carbohydrate chain of heparan sulfate and other heparin-like molecules. It is noteworthy that this phenotype was also demonstrated for the CHO cell mutant pgsD-677 (14) .
Glycoprotein processing and transport in gro2C cells. It is well established that defects in glycoprotein processing or secretion can interfere with HSV propagation, as has been demonstrated for a variety of somatic cell mutants (2, 4, 24) . Moreover, a previously isolated BHK cell mutant, RicR14, which is partially herpesvirus resistant, has been shown to express undersulfated heparan sulfate proteoglycans on the cell surface as well as defects in N glycosylation (5) . To test whether the gro2C mutant contained a second defect in protein glycosylation or secretion that could account for its apparent herpesvirus resistance phenotype, we analyzed the synthesis and processing of the well-characterized glycoprotein VSV G. VSV G protein was chosen for these assays because its transport and glycoprotein processing have been characterized in a wide variety of previously existing somatic cell mutants (23) . Monolayers of L cell controls, gro2C, and the secretion mutant gro29 (2, 24) were exposed to VSV and examined at 4 h postinfection by a pulse-chase labeling analysis. Infected cells were incubated for 15 min with [3 S]methionine to label viral proteins. Proteins were then examined immediately postlabeling or incubated for an additional 15 or 45 min to allow the VSV G protein to traverse the secretory organelles prior to harvest (Fig. 4) . It can be seen that all three cell lines were susceptible and permissive to VSV and synthesized normal amounts of glycosylated VSV G glycoprotein during the labeling period. bility of VSV G protein in the gel (compare Fig. 4A and B) . By contrast, there was no apparent flux of G protein in the gro29 secretory mutant, which serves as a control to denote the position of underprocessed G protein accumulating under conditions of reduced secretion (24) . After 45 min of chase, VSV G proteins synthesized by L and gro2C cells were fully processed, whereas there was little evidence for processing in gro29 cells. We conclude from these results that gro2C is normal with regard to N glycosylation and as such is distinct from other well-characterized glycosylation mutants shown previously to interfere with HSV propagation.
Analysis of virus plaques in mutant cell monolayers. The isolation of permissive cells lacking heparan sulfate proteoglycan synthesis allowed us to test whether heparan sulfate proteoglycan synthesis is required for the production of HSV progeny. To determine whether HSV-1 plaques form on gro2C cell monolayers, mutant and control cells were exposed to HSV-1 at different concentrations and incubated for several days to allow for plaque formation (Fig. 5) . In these assays, the number of plaques on gro2C monolayers was reduced by 85% + 5% (n = 3) compared with parental L cells, consistent with the partial herpesvirus resistance phenotype first observed for gro2C cell monolayers. Interestingly, the gro2C plaques were similar in size and morphology to L cell plaques, indicating that there was no impediment to infectious center formation or to virus propagation and spread from cell to cell. It is also noteworthy that the number of gro2C plaques increased with virus concentration such that the entire monolayer was destroyed at high virus concentrations. This result indicates that every cell in the gro2C monolayer was susceptible to infection. It is likely, therefore, that the reduction in plaque number on gro2C monolayers at each concentration of input virus is caused by a failure to efficiently infect the gro2C cells during the initial exposure to the virus.
The data so far indicated that HSV-1 was able to spread from cell to cell in gro2C cell monolayers. To test whether HSV-infected gro2C cells were able to release infectious virions, growth curves of intracellular and extracellular HSV-1 were generated (Fig. 6) . When L cells were infected with HSV-1 at an MOI of 10 ( Fig. 6A) , intracellular infectious virus was detected by 5 to 7 h postinfection, and infectious virus was released from the cell by 7 to 9 h postinfection. A similar pattern of accumulation of intracellular virus and extracellular virus was observed for gro2C cells when they were infected with the same amount of virus (Fig. 6B) . Taken together, these results show that the HSV-1 life cycle is not impeded by the failure of the gro2C host cells to synthesize heparin-like molecules.
To test whether the progeny virus produced by mutant gro2C cells was similar to wild-type virus, monolayers of control L cells and gro2C cells were infected with progeny virus released from gro2C cells. In these assays, there was an 85% reduction in plaque formation on gro2C cells compared with control L cell monolayers (data not shown). Thus, it appeared that the virus produced by gro2C cells was similar to wild-type virus in its ability to distinguish between control and gro2C cell monolayers in the plaque assay.
DISCUSSION
This report describes the isolation and characterization of a mammalian cell mutant that is defective in heparan sulfate biosynthesis. Although it cannot be concluded with certainty that gro2C synthesizes no heparan sulfate chains, the assays used for this study were sensitive enough to detect 0.05% or less of the normal complement of heparan sulfate. It has been estimated that typical concentrations of heparan sulfate proteoglycans on the cell surface of a variety of cell types are in the range of 105 to 106 molecules per cell (8) and that 105 heparan sulfate proteoglycans present on the surface of a cell would cover the cell surface if the heparan sulfate chains were extended and mobile around the anchored core proteins (27) . These estimates indicate that the cell surface of gro2C must be largely devoid of heparan sulfate.
Despite this deficiency, the cells are reasonably good targets for infection, considering that a >99.95% reduction in heparan sulfate expression reduces the infection efficiency of HSV-1 by only 85% (Fig. 5) . These results suggest that HSV-1 need not interact specifically with heparan sulfate to gain entry into mouse fibroblasts. In this regard, it has been shown that the most likely candidate for the initial interaction with heparan sulfate is the viral glycoprotein gC, which is not essential for infectivity in culture. However, its presence in the virion enhances infectivity by a factor of 10 (7). It is noteworthy that we also observed an 8-to 10-fold reduction in infectivity in the absence of heparan sulfate (Fig. 5) . Taken together, these results suggest that the principal role of gC during infection in culture is to interact with heparan sulfate to promote efficient virus entry.
Although the events of the virus entry pathway have not yet been well characterized, it is clear that at least three HSV glycoproteins, gB, gD, and gH, are essential for virus infection (3, 15, 16, 19) . It may be the case that one or more of these viral glycoproteins engages a second cell surface receptor to facilitate virus entry. It has been proposed that gD may bind a cell surface component (10) (11) (12) , which could serve to anchor virions at the surface or promote subsequent events such as fusion with the plasma membrane. Our results showing that gro2C cells can be infected by HSV-1 are consistent with a mechanism that allows the virus to interact productively with a second receptor without first interacting with heparan sulfate. This second interaction is apparently strong enough to account for the residual 15% infectivity demonstrated for gro2C cells in the absence of heparan sulfate.
It is clear from our studies and those of others (20) that soluble heparan sulfate is incapable of linking the virus to the host cell so as to overcome the lack of endogenously synthesized heparan sulfate (Fig. 1) . This finding is consistent with previous results which showed that ["5S]sulfatelabeled proteoglycans isolated from the medium of human fibroblast cultures are not incorporated into the extracellular matrix when added to unlabeled cell cultures (9 In several respects, the gro2C phenotype resembles that of the CHO mutant cell line pgsD-677 (14) . Both cell lines are defective in heparan sulfate synthesis and show some similarities with regard to their interactions with HSV. Whereas both cell lines are infected by HSV-2 (20, 23a) , only gro2C cells can be infected with HSV-1. We are intrigued by the differences observed for gro2C versus pgsD-677 cells and propose that the removal of heparan sulfate from these cells has uncovered cell type differences in the cell surface molecules that facilitate the entry of HSV-1. Mouse L cells appear to express receptors for both HSV-1 and HSV-2 for which prior binding to heparan sulfate is not essential. By contrast, HSV-1 appears to gain entry to CHO cells via a molecule that functions poorly for virus entry without the help of the heparan sulfate interactions. It is intriguing to speculate that the relatively nonpermissive CHO cells have lost a functional receptor for HSV-1. If the entry of HSV-1 into CHO cells is via an alternative pathway, it may be that this pathway renders the virus unable to initiate infection efficiently. We would also infer from these results that the cellular components used by HSV-2 to gain entry to CHO and L cells are functional in the absence of heparan sulfate.
Characterization of the role of heparan sulfate proteoglycans in the HSV life cycle was also extended to postinfection events. Although virus attachment assays revealed that gro2C cells are relatively inefficient targets for stable virus attachment, one-step growth experiments show that virus gene expression and subsequent virus assembly and egress occur normally after virus uptake (Fig. 6) . Moreover, plaque assays reveal that all of the gro2C cells are ultimately susceptible to infection: increasing the input PFU increases the number of plaques formed. Taken together, these results provide strong evidence that once a gro2C cell is infected, virus propagation ensues unperturbed by the virtual absence of heparan sulfate moieties in the host cell. This finding implies that none of the 10 herpesvirus glycoproteins identified need to be modified by the addition of heparan sulfate chains during virus propagation. Moreover, virions do not require heparan sulfate in the cell or medium to become infectious.
The most striking observation to come from this study is that gro2C cells, like pgsD-677 cells, have a specific defect in heparan sulfate polymerization and are poor targets for the stable attachment of HSV. These results provide strong evidence that heparan sulfate proteoglycans play a major role in facilitating herpesvirus infection in cells normally expressing these molecules. This conclusion is strengthened by the fact that the two mutant cell lines arose by different selection procedures: pgsD-677 were screened for a reduction in sulfate incorporation (14) , whereas gro2C were selected for the ability to survive exposure to HSV-1. This fact virtually eliminates the possibility that a second mutation that could account for the herpesvirus resistance phenotype arose fortuitously in both cell lines during selection. In this regard, we have found that a high percentage of the cell lines isolated by the herpesvirus selection procedure are proteoglycan synthesis mutants. Because of the permissivity of mouse L cells to a variety of herpesviruses, these cellular mutants should be useful tools for identifying and characterizing viral glycoprotein-proteoglycan interactions. Moreover, the availability of glycoprotein-deficient herpesviruses should facilitate these investigations.
The results presented in this study suggest that HSV can be a powerful selective agent for identifying cellular components that are critical to the virus entry pathway. Furthermore, we are intrigued that the cell lines isolated in this way are killed when they are rechallenged with virus, which suggests that a second round of selection could be used to isolate mutants that are no longer susceptible to infection. Ideally, these cells would be defective in expressing additional components of the cellular machinery used by the virus to gain entry to the cell and could be useful for identifying these molecules.
